-
Breaking Research News from Breastcancer.org
Breastcancer.org strives to bring you updates on the latest breast cancer research through its Research News program. Medical experts at Breastcancer.org provide easy-to-understand summaries of what the research means for YOU. Favorite this thread to get notifications on all the breaking news about current breast cancer…
-
Breastcancer.org Podcasts: Experts discuss research & issues
Our podcasts feature experts discussing a wide variety of breast cancer issues and the latest research on breast cancer. Check out all of Breastcancer.org's Podcasts here. In the premiere podcast, we're excited to bring you a summary of the research highlights from first day of the San Antonio Breast Cancer Symposium 2013!…
-
Breastcancer.org News Hub
Check out our reporting on trending breast cancer news in our one-of-a-kind and frequently updated News Hub:
-
Top Breast Cancer Research in 2024
Please check out our coverage of all the important research we've covered this year!
-
Breastcancer.org Research Conferences Coverage
Breastcancer.org is dedicated to bringing you the latest in breast cancer research by sending our reporters to get boots-on-the-ground breaking information at annual breast cancer conferences whenever possible. Here, we'll share our coverage and this thread will be updated as necessary in real time — make sure to bookmark…
-
Dana Farber 2022-2023 EMBRACE MBC Virtual Forum Series
Hi all! We wanted to share with you a helpful series of five free online virtual forums about promising areas of research and treatment in metastatic breast cancer hosted by Dana Farber's 2022-2023 EMBRACE MBC program. You can access the recordings here: * Welcome Session | 2022-2023 EMBRACE MBC Virtual Forum Series *…
-
Top Research at SABCS 2024
Top Research at SABCS 2024 Dec 13, 2024 What were the hot topics at the 2024 SABCS? Dr. Marisa Weiss details the highlights. The 2024 San Antonio Breast Cancer Symposium featured five days of research presentations, educational sessions, and advocacy meetings. Dr. Marisa Weiss, founder and chief medical officer of…
-
Metformin-Anyone on this trial?
My onc suggested I go on this trial after I finish chemo. Is anyone else on this trial?
-
SBRT vs. Histrotripsy for Liver Mets
Hello, I am weighing the options of treating my liver mets with either histotripsy or SBRT. I am in communication with 2 different physicians, one who treats with histotripsy and the other with SBRT. The physician that uses histotripsy is still in the process of reviewing my images, and is expected to contact me soon as to…
-
Clever study
Hi! Anyone on a clinical trial targeting dormant cells? ( like Clever study).
-
Breaking Research News from sources other than Breastcancer.org
I watch for research news on breast cancer, treatments, etc., and frequently see interesting articles. There is a topic on BCO called "Breaking Research News from Breastcancer.org." One of the moderators suggested that another topic might be appropriate for posting links and synopses of reports on research found elsewhere.…
-
Summer 2024 Breast Cancer Research Round Up
Summer 2024 Breast Cancer Research Round Up Aug 30, 2024 What does the latest breast cancer research mean for you? Dr. Holly Pederson explains. The U.S. Preventive Services Task Force updated its screening mammogram recommendations. Having a double mastectomy after being diagnosed with breast cancer in one breast doesn’t…
-
TORADOL (ketorolac) linked to Recurrence Prevention
My mantra for medical and nursing information for decades has been " Just when you think you know something look again" I thought I was done searching for an answer yesterday on something else, then I listened, "You don't know enough, look again, you don't know enough look again". That pesky little irritating voice that…
-
Primary lung cancer after treatment with chemo
Just read this article - https://www.epicresearch.org/articles/women-with-breast-cancer-especially-those-who-received-chemotherapy-at-increased-risk-for-subsequent-lung-cancer Apparently new information has come out showing a higher rate for primary lung cancer after breast cancer treatment with chemo. Something like a 57%…
-
Top Breast Cancer Research at ASCO 2024
Top Breast Cancer Research at ASCO 2024 Jun 2, 2024 Dr. Eleonora Teplinsky explains the results with the most immediate implications for people with breast cancer. The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting featured five days of presentations and educational sessions on all types of cancer. Dr.…
-
Finding and Treating Inactive Breast Cancer Cells
Finding and Treating Inactive Breast Cancer Cells Feb 2, 2024 Dr. Angela DeMichele explains her research on treating inactive breast cancer cells to prevent recurrence. At the European Society for Medical Oncology 2023 Congress, Dr. DeMichele presented results from the CLEVER study, which looked at ways to treat inactive…
-
Anyone who was in the KRISTINE Clinical Trial? Let's connect!
Hello, Is there anyone on this site who was in the KRISTINE CLINICAL TRIAL? I'm 8.4 years out and trying to connect with someone who was in the trial. Really concerned about recurrance during and after the trial. Hope to hear from you! It's been a lonely journey in this trial. Hugs,
-
liquid biopsy for early monitoring and outcome prediction
Multimodal liquid biopsy for early monitoring and outcome prediction of chemotherapy in metastatic breast cancer https://www.nature.com/articles/s41523-021-00319-4...
-
Research With Immediate Impact at 2023 SABCS
Research With Immediate Impact at 2023 SABCS Dec 8, 2023 Dr. Matthew Goetz tells us about the research that will change the way he talks to his patients. The 2023 San Antonio Breast Cancer Symposium featured five days of research presentations, educational sessions, and advocacy meetings. Dr. Matthew Goetz, noted breast…
-
Verzenio + fulvestrant increased OS in ER+/HER2+ MBC
I guess this could eventually mean a new first line for estrogen positive HER2+ patients. This was just a Phase 2 trial so I suppose there has to be a Phase 3 before it would become common in clinical use. Looks like they didn’t include Perjeta (pertuzumab) in this protocol, either. CONCLUSION: In this phase II trial,…
-
Oncologist webinar and Q&A on ESR1 mutations
I came across this and thought it might be helpful to some as it has a Q&A with an oncologist and is just for patients. It is about ESR1 mutations and what treatments are available that target it. Here is the info: https://us02web.zoom.us/webinar/register/3716946173479/WN_I7tieDjBTzmi7n67dP3Nwg
-
Scientists make promising discovery in fight against breast cancer
-
Genomic Assay Changes Minds on HER2+ Breast Cancer Treatment
Genomic Assay Changes Minds on HER2+ Breast Cancer Treatment https://www.medscape.com/s/viewarticle/992154 HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial…
-
Incredible hopeful study published in BMJ today
-
Podcast: 2023 ASCO Takeaways
-
ASCO 2023 BCO Coverage
Check out our continuing coverage of the 2023 American Society of Clinical Oncology Annual Meeting here:
-
2023 ASCO abstracts
All abstracts…
-
Identifying the optimal therapeutics ... ER+ & Her2+
Identifying the optimal therapeutics for patients with hormone receptor- positive, HER2-positive advanced breast cancer: a systematic review and network meta-analysis https://www.sciencedirect.com/scienc...59702923004428
-
Clinical utility of liquid biopsy in breast cancer: A systematic review
Clinical utility of liquid biopsy in breast cancer: A systematic review DefineMBC™: A clinical experience summary from 25 United States-based cancer centers on the clinical utility of a comprehensive liquid biopsy in metastatic breast cancer https://www.oncology-central.com/wp-...per_1Nov22.pdf
-
List of sequential regimens particular to your condition.
Hello, If there is a program that takes relevant condition (stage, pathology, treatment history, etc) of your illness, and based on current published research (from ASCO, SABCS, ESSO, MBCC, etc), the program generates a list of sequential regimens specific to you. The program continuously update the regimen list as…
-
Podcast: 2022 SABCS Key Take-Aways
2022 SABCS Key Take-Aways Dec 13, 2022 Dr. Stephanie Graff explains the most interesting research presented at the 2022 San Antonio Breast Cancer Symposium. The 2022 San Antonio Breast Cancer Symposium featured five days of research presentations, educational sessions, and posters. The amount of research presented can be…
-
Anyone interested in participating in a paid research study?
Hi All. I am participating in a paid study for breast cancer patients. Here is the info in case anyone is interested. Just send Devi an email if you are interested and she will get back to you to screen you for the study. **********Her email to me ******************** We have quite a range of different things. But we will…
-
BCO Conference Coverage: SABCS 2022
Every December, the San Antonio Breast Cancer Symposium brings together clinicians, researchers, and advocates to discuss the latest breast cancer study results. We're proud to present our coverage below. ***Stay tuned to this thread as more coverage is added!***
-
Research into Targeted Radiotherapy for LeptoMeningeal Mets
I got this info from Metavivor social media and searched for articles on it. Good to see this is happening. Plus Therapeutics Awarded 17.6 Million Dollars from the State of Texas https://www.globenewswire.com/news-release/2022/08/17/2500436/0/en/Plus-Therapeutics-Awarded-17-6-Million-from-State-of-Texas.html “LM is one of…
-
Podcast: Just Ask: Increasing Diversity in Clinical Trials
Just Ask: Increasing Diversity in Clinical Trials May 27, 2022 Dr. Nadine Barrett discusses why diversity in clinical trials is so important and how the Just Ask program helps address that lack of diversity. Listen to the episode to hear Dr. Barrett talk about: *why diversity in in clinical trials is so important *what the…
-
High dose estrogen therapy for breast cancer
The use of high-dose estrogens for the treatment of breast cancer - PubMed (nih.gov) Abstract Estrogens are known to stimulate the growth of breast cancer but they are also an effective treatment for this disease (this has been termed the 'estrogen paradox'). The fact that estrogens can be an effective treatment for breast…